SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Pathways (CLPA) -- Ignore unavailable to you. Want to Upgrade?


To: StockMiser who wrote (308)10/29/1999 8:56:00 AM
From: StockMiser  Respond to of 566
 
Cell Pathways Raised to 'Buy' at Janney Montgomery

Princeton, New Jersey, Oct. 28 (Bloomberg Data) -- Cell Pathways Inc.
(CLPA US) was raised to ''buy'' from ''accumulate'' by analyst Heather D.Morris at Janney Montgomery Scott. The 12-month target price is $20.00 per share.

--------